Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia

E-ISSN： 2212-3873|6|3|249-258

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.3, 2006-09, pp. : 249-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of vasopressin receptor antagonists in hyponatremia

By Elhassan Elwaleed A Schrier Robert W

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 373-380

Informa Healthcare

Access to resources Recommend Favorite

Is vasopressin-receptor antagonism an advancement in the treatment of heart failure?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2181-2184

Informa Healthcare

Access to resources Recommend Favorite

Adenosine A 2A receptor antagonists as new agents for the treatment of Parkinson's disease

By Richardson P.J. Kase H. Jenner P.G.

Trends in Pharmacological Sciences, Vol. 18, Iss. 9, 1997-10 ,pp. : 338-344

Elsevier

Access to resources Recommend Favorite

Smoothened antagonists: a promising new class of antitumor agents

By Gallinari Paola Filocamo Gessica Jones Philip Pazzaglia Simonetta Steinkühler Christian

Expert Opinion on Drug Discovery, Vol. 4, Iss. 5, 2009-05 ,pp. : 525-544

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Vasopressin Receptor Antagonists

By Ali Farhan Guglin Maya Vaitkevicius Peter Ghali Jalal K.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 847-858

Adis International

Access to resources Recommend Favorite